364 filings
Page 4 of 19
6-K
qysu32yvx9
4 May 21
BioLineRx Announces Positive Top-Line Results from
7:12am
6-K
1fnuxouo5ovm
15 Apr 21
BioLineRx Announces Presentation at 2021 American
4:01pm
6-K
eymnz ypz5n3o
5 Apr 21
Current report (foreign)
4:30pm
6-K
y744ojwel
26 Feb 21
Extraordinary General Meeting of Shareholders on
4:30pm
6-K
dnxch4 28p01dixdlj39
23 Feb 21
BioLineRx Reports Year-End 2020 Financial Results
7:02am
6-K
ek0ymapzz
22 Jan 21
BioLineRx Announces Closing of $34.5 Million Bought Deal Offering and Full Exercise of
4:21pm
6-K
74rwsw36
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
cattmxc3ky 7h5
16 Dec 20
Current report (foreign)
8:00am
6-K
tz3v7gy1ancounpi
16 Dec 20
BioLineRx Announces Final Results from Phase 2a
6:02am
6-K
vts9d
23 Nov 20
BioLineRx Reports Third Quarter 2020 Financial Results
7:08am
6-K
6x9x6iy pqhbtg4
18 Nov 20
BioLineRx Announces Initiation of Phase 1b Clinical Trial
7:09am
6-K
gaf7kh7rzjce
30 Oct 20
BioLineRx Announces Positive Results from Interim Analysis of
7:09am
6-K
qe0lbt7i
29 Oct 20
BioLineRx Announces Initiation of Phase 2 Clinical Trial
8:45am
6-K
puqyigdlp9 jdzycio
25 Sep 20
Current report (foreign)
4:33pm
6-K
4ujbskbrf2r553
24 Sep 20
Current report (foreign)
4:30pm
6-K
mme3 hz9xgu2qx9y
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm
6-K
woaps4a5835
19 Aug 20
BioLineRx Achieves Enrollment Target in Phase 3
7:08am
6-K
epany0fi9r
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am
6-K
w7vluj 8rjuhq1r0ld
3 Jun 20
Current report (foreign)
8:30am
6-K
40xeymja
1 Jun 20
BioLineRx Announces $4.39 Million Registered Direct Offering
8:05am